Topic: COVID vaccination

CCU081

People with autoimmune rheumatic diseases, where the immune system attacks its own body, are more likely to have heart attacks and other cardiovascular (CV) diseases than the general population. Idiopathic inflammatory myopathy (IIM) is a rare autoimmune disease where both… Read more

CCU059

An estimated 14 million people in England are living with two or more chronic conditions, referred to Multiple Long-Term Conditions (MLTC). We know that people living with MLTC have a higher risk of being admitted to hospital and of dying… Read more

CCU068

CCU068
Congenital heart disease (CHD) is the commonest birth defect, affecting just under 1% of the population – at least 700,000 people in the UK. Work we have done in UK general practice patients, using information predating mass COVID vaccination, has… Read more

CCU051

The benefits of Covid-19 vaccinations are well-known; they reduce the risk of infection and lower the risk of serious illness or death associated with Covid-19. Evidence in England and Scotland suggests rates of COVID-19 hospitalisation and COVID-19 death are around… Read more

CCU048

There is strong evidence that infections with certain viruses making it more likely for someone to develop psychotic disorders, such as schizophrenia. Since the start of the COVID-19 pandemic, we have seen more people seeking treatment for psychosis symptoms in… Read more

CCU039

Mass rollout of several highly-effective Covid-19 vaccines has helped prevent severe cases of Covid-19, protecting against hospitalisation and death. However, uptake of Covid-19 vaccination has not been equal across the population, potentially exacerbating existing health inequalities and leaving some communities… Read more

CCU036

This research project is awarded through a funding call by Health Data Research UK and the Alan Turing Institute as part of the wider Data and Connectivity National Core Study. Further details on this project are available here. Outputs COVID-19… Read more

CCU023

COVID-19 vaccine rollout in the UK has been very successful. However, how long immunity from SARS-Cov-2 – the virus that causes COVID-19 – will last with vaccines is unknown. It is also unknown if new vaccines will need to be… Read more